From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out and who I spoke with to break it all down.
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
Abbott's new app brings much needed upgrades like silence Low Alarms and control of all sensors under one umbrella.
The soon-to-be-released insulin pump inspired by DIY Loop offers Apple Watch control, advanced occlusion detection, and glycemic value carb logging.
